I am an independent healthcare analyst and freelance writer specializing in healthcare policy. My work focuses on the pricing and reimbursement of biopharmaceuticals, as well as the regulatory and legislative policies that shape patient access and public health.

Currently, I am engaged in several research and writing projects. These include freelance assignments for Forbes and other publications, where I analyze the impact of the Inflation Reduction Act on patients, drug manufacturers, and payers. I am also studying the pricing and reimbursement of orphan and cancer drugs and exploring how HIV medicines influence healthcare costs, utilization, and outcomes.